Article, 2024

Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, Volume 13, 7, 10.3390/jcm13072033

Contributors

Bucci, Tommaso 0000-0003-2895-6234 [1] [2] [3] Del Sole, Francesco 0000-0002-7781-6636 [1] Menichelli, Danilo 0000-0001-9467-5903 [1] Galardo, Gioacchino 0000-0001-5941-9947 [1] Biccire, Flavio G. [1] Farcomeni, Alessio [4] Lip, Gregory Y. H. [2] [3] [5] Pignatelli, P 0000-0002-2265-7455 (Corresponding author) [1] Pastori, Daniele 0000-0001-6357-5213 [1] [2] [3]

Affiliations

  1. [1] Sapienza Univ Rome, Dept Clin Internal Med Anaesthesiol & Cardiovasc S, I-00161 Rome, Italy
  2. [NORA names: Italy; Europe, EU; OECD];
  3. [2] Heart & Chest Hosp, Liverpool L7 8TX, England
  4. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  5. [3] Univ Liverpool, Liverpool John Moores Univ & Liverpool, Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg, Liverpool L7 8TX, Lancashire, England
  6. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  7. [4] Univ Roma Tor Vergata, Dept Econ & Finance, Via Columbia 2, I-00133 Rome, Italy
  8. [NORA names: Italy; Europe, EU; OECD];
  9. [5] Aalborg Univ, Danish Ctr Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
  10. [NORA names: AAU Aalborg University; University; Denmark; Europe, EU; Nordic; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

bleeding, coronary artery disease, major adverse cardiovascular events, peripheral artery disease, rivaroxaban

Data Provider: Clarivate